Apr 05, 2017 at 21:42 | Source: PTI
Bayer Pharma Aktiengesellschaft and Bayer Australia Ltd had filed a patent infringement lawsuit against Generic Health Pty Ltd and Lupin Australia Pty Ltd, subsidiaries of the company, in the Federal Court of Australia, Lupin said in a filing to BSE.
Mar 26, 2017 at 22:00 | Source: PTI
"This is a great victory for our farmers, for citizens of India, as now the CCI has stopped the poison makers - Monsanto and Bayer from merging in India.
Feb 22, 2017 at 22:24 | Source: Reuters
German drugs and pesticides maker Bayer forecast a year without earnings growth for its agricultural products business on Wednesday, as it seeks to complete its USD66 billion deal to take over U.S. seeds giant Monsanto.
Feb 20, 2017 at 16:21 | Source:
Axis Direct recommended hold rating on Bayer Cropscience with a target price of Rs 4050 in its research report dated February 17, 2017.
Feb 16, 2017 at 15:44 | Source:
Lupin has received final USFDA approval for ANDA Moxifloxacin Hydrochloride Tablets, 400 mg. Generic of Avlox Tablets of Bayer Healthcare Pharmaceuticals, Inc.
Feb 08, 2017 at 08:00 | Source: CNBC-TV18
Infosys | Idea Cellular | Axis Bank | Tata Steel | Bharti Airtel | Bharat Forge | Hero Motocorp | Godawari Power | Jubilant Life Sciences | NHPC | Quess Corp | Titan Company and Jindal Stainless are stocks, which are in the news today.
Feb 07, 2017 at 22:14 | Source: PTI
Bayer CropScience Ltd today reported 26 per cent rise in its net profit at Rs 36.8 crore for the quarter ended December.
Jan 25, 2017 at 11:21 | Source:
Bayer CropScience Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 07, 2017, to take on record the Unaudited Financial Results & Limited Review Report of the Company for the quarter ended December 31, 2016 (Q3).
Dec 14, 2016 at 11:33 | Source:
Shareowner of Monsanto Company approved the merger of Monsanto with a wholly owned subsidiary of Bayer Aktiengesellschaft.
Dec 14, 2016 at 08:10 | Source: Reuters
Increased research and development spending by the combined companies and plans to develop a global seeds and biotechnology hub in St. Louis fuel hopes regulators will not block the deal, which was agreed upon in September, Monsanto CEO Hugh Grant said.
Messages on Bayer »


New Member


Bayer CropScien  

up to coming friday bayer will cross 5000 mark

about 1 hr 33 min 57 sec ago


Platinum Member


Bayer CropScien  

Arvind sir you rock....what is the target you see on Bayer?

about 1 hr 50 min 54 sec ago

Monsanto India  

Look at Bayer if Monsanto is related to Bayer the why not moving up

about 2 hrs 14 min 38 sec ago


New Member


Bayer CropScien  

arvind sir pls empire ind aap aagr watch karte ho to advice dea pls 2000 rs par chal raha hea .kiya yea bhi bayer ki tarha bhav ho sakta hea.aap ray mahatv purn hea

about 3 hrs 50 min 17 sec ago


New Member



arvind ji bayer cropscience is blasting !!!!!holding with patience as u mentioned once that its ur favourite stock.what target we may partially book?

about 4 hrs 31 min 8 sec ago


New Member



UPL scaled 806 and ought to meet Citi s target 860. UPL`s PE 26 much lower than peers Bayer, Dhanuka, Monsanto, PI Industries. UPL is #1 crop solutions provider in India, product registration in 124 countries, 388 patents filed, 80% sales from branded products.

about 4 hrs 52 min 46 sec ago

Monsanto India  

As long as Bayer is moving , MIL will not move. Bayer and MIL very rarely move together.

about 4 hrs 56 min 37 sec ago


New Member


Bayer CropScien  

Will you invest in Bayer CropScience for wealth creation? Now get stock market updates for Free. Check this out... 👉

9.22 PM Apr 24th


New Member


Rupa and Comp  

arvindji please suggest your target for bayer and kpit exit trigger thanks

2.01 PM Apr 24th

Monsanto India  

MIL has moved above 2550 but it has habit of giving false buy signals. Hope this thine it is a real buy signal and as Bayer also showing signs of fresh rally, one can definitely consider buying MIL with a target of 3000.

12.48 PM Apr 24th

Follow us on
Available On